ID   1433B_MOUSE             Reviewed;         246 AA.
AC   Q9CQV8; O70455; Q3TY33; Q3UAN6;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   05-DEC-2018, entry version 173.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=Ywhab;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Karpitskiy V.V., Shaw A.S.;
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RC   TISSUE=Bone marrow, Embryo, Kidney, Liver, Thymus, and Visual cortex;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-12; 14-57; 61-70; 84-117; 128-169; 196-246 AND
RP   215-224, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=C57BL/6J, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Kang S.U., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [4]
RP   PHOSPHORYLATION AT SER-60.
RX   PubMed=9705322; DOI=10.1074/jbc.273.34.21834;
RA   Megidish T., Cooper J., Zhang L., Fu H., Hakomori S.;
RT   "A novel sphingosine-dependent protein kinase (SDK1) specifically
RT   phosphorylates certain isoforms of 14-3-3 protein.";
RL   J. Biol. Chem. 273:21834-21845(1998).
RN   [5]
RP   INTERACTION WITH SYNPO2.
RX   PubMed=15883195; DOI=10.1083/jcb.200411169;
RA   Faul C., Huettelmaier S., Oh J., Hachet V., Singer R.H., Mundel P.;
RT   "Promotion of importin alpha-mediated nuclear import by the
RT   phosphorylation-dependent binding of cargo protein to 14-3-3.";
RL   J. Cell Biol. 169:415-424(2005).
RN   [6]
RP   NITRATION [LARGE SCALE ANALYSIS] AT TYR-84 AND TYR-106, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16800626; DOI=10.1021/bi060474w;
RA   Sacksteder C.A., Qian W.-J., Knyushko T.V., Wang H., Chin M.H.,
RA   Lacan G., Melega W.P., Camp D.G. II, Smith R.D., Smith D.J.,
RA   Squier T.C., Bigelow D.J.;
RT   "Endogenously nitrated proteins in mouse brain: links to
RT   neurodegenerative disease.";
RL   Biochemistry 45:8009-8022(2006).
RN   [7]
RP   INTERACTION WITH PRKCE.
RX   PubMed=18604201; DOI=10.1038/ncb1749;
RA   Saurin A.T., Durgan J., Cameron A.J., Faisal A., Marber M.S.,
RA   Parker P.J.;
RT   "The regulated assembly of a PKCepsilon complex controls the
RT   completion of cytokinesis.";
RL   Nat. Cell Biol. 10:891-901(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   INTERACTION WITH SAMSN1.
RX   PubMed=20478393; DOI=10.1016/j.biocel.2010.05.004;
RA   Brandt S., Ellwanger K., Beuter-Gunia C., Schuster M., Hausser A.,
RA   Schmitz I., Beer-Hammer S.;
RT   "SLy2 targets the nuclear SAP30/HDAC1 complex.";
RL   Int. J. Biochem. Cell Biol. 42:1472-1481(2010).
RN   [10]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with
RT   14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2. Negative regulator of
CC       signaling cascades that mediate activation of MAP kinases via
CC       AKAP13. {ECO:0000250|UniProtKB:P31946}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with SAMSN1 and
CC       PRKCE (PubMed:18604201, PubMed:20478393). Interacts with AKAP13.
CC       Interacts with SSH1 and TORC2/CRTC2. Interacts with ABL1; the
CC       interaction results in cytoplasmic location of ABL1 and inhibition
CC       of cABL-mediated apoptosis. Interacts with ROR2 (dimer); the
CC       interaction results in phosphorylation of YWHAB on tyrosine
CC       residues. Interacts with GAB2. Interacts with YAP1 (phosphorylated
CC       form). Interacts with the phosphorylated (by AKT1) form of SRPK2.
CC       Interacts with PKA-phosphorylated AANAT. Interacts with MYO1C.
CC       Interacts with SIRT2 (By similarity). Interacts with the 'Thr-369'
CC       phosphorylated form of DAPK2 (PubMed:26047703). Interacts with
CC       PI4KB, TBC1D22A and TBC1D22B. Interacts with the 'Ser-1134' and
CC       'Ser-1161' phosphorylated form of SOS1 (By similarity). Interacts
CC       (via phosphorylated form) with YWHAB; this interaction occurs in a
CC       protein kinase AKT1-dependent manner (By similarity). Interacts
CC       with SLITRK1 (By similarity). Interacts with SYNPO2
CC       (phosphorylated form); YWHAB competes with ACTN2 for interaction
CC       with SYNPO2 (PubMed:15883195). Interacts with RIPOR2 (via
CC       phosphorylated form); this interaction occurs in a chemokine-
CC       dependent manner and does not compete for binding of RIPOR2 with
CC       RHOA nor blocks inhibition of RIPOR2-mediated RHOA activity (By
CC       similarity). {ECO:0000250|UniProtKB:P31946,
CC       ECO:0000269|PubMed:15883195, ECO:0000269|PubMed:18604201,
CC       ECO:0000269|PubMed:20478393, ECO:0000269|PubMed:26047703}.
CC   -!- INTERACTION:
CC       Q5S006:Lrrk2; NbExp=3; IntAct=EBI-771608, EBI-2693710;
CC       P16054:Prkce; NbExp=6; IntAct=EBI-771608, EBI-298451;
CC       Q91YE8:Synpo2; NbExp=3; IntAct=EBI-771608, EBI-7623057;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P31946}.
CC       Melanosome {ECO:0000250|UniProtKB:P31946}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q9CQV8-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q9CQV8-2; Sequence=VSP_018634;
CC         Note=No experimental confirmation available. Contains a
CC         N-acetylmethionine at position 1. {ECO:0000250};
CC   -!- PTM: Isoform alpha differs from isoform beta in being
CC       phosphorylated (By similarity). Phosphorylated on Ser-60 by
CC       protein kinase C delta type catalytic subunit in a sphingosine-
CC       dependent fashion. {ECO:0000250, ECO:0000269|PubMed:9705322}.
CC   -!- PTM: Isoform Short contains a N-acetylmethionine at position 1.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
DR   EMBL; AF058797; AAC14343.1; -; mRNA.
DR   EMBL; AK002632; BAB22246.1; -; mRNA.
DR   EMBL; AK004872; BAB23631.1; -; mRNA.
DR   EMBL; AK011389; BAB27587.1; -; mRNA.
DR   EMBL; AK083367; BAC38886.1; -; mRNA.
DR   EMBL; AK144061; BAE25678.1; -; mRNA.
DR   EMBL; AK150414; BAE29538.1; -; mRNA.
DR   EMBL; AK151294; BAE30278.1; -; mRNA.
DR   EMBL; AK158932; BAE34730.1; -; mRNA.
DR   CCDS; CCDS17019.1; -. [Q9CQV8-1]
DR   RefSeq; NP_061223.2; NM_018753.6. [Q9CQV8-1]
DR   RefSeq; XP_006499972.1; XM_006499909.1. [Q9CQV8-1]
DR   UniGene; Mm.34319; -.
DR   UniGene; Mm.491117; -.
DR   PDB; 4GNT; X-ray; 2.41 A; A=1-239.
DR   PDB; 5F74; X-ray; 2.35 A; A=1-246.
DR   PDB; 5WFU; X-ray; 1.97 A; A/B/C/D=1-246.
DR   PDB; 5WFX; X-ray; 1.65 A; A/B=1-246.
DR   PDBsum; 4GNT; -.
DR   PDBsum; 5F74; -.
DR   PDBsum; 5WFU; -.
DR   PDBsum; 5WFX; -.
DR   ProteinModelPortal; Q9CQV8; -.
DR   SMR; Q9CQV8; -.
DR   BioGrid; 207648; 31.
DR   IntAct; Q9CQV8; 635.
DR   MINT; Q9CQV8; -.
DR   STRING; 10090.ENSMUSP00000018470; -.
DR   iPTMnet; Q9CQV8; -.
DR   PhosphoSitePlus; Q9CQV8; -.
DR   SwissPalm; Q9CQV8; -.
DR   UCD-2DPAGE; Q9CQV8; -.
DR   PaxDb; Q9CQV8; -.
DR   PeptideAtlas; Q9CQV8; -.
DR   PRIDE; Q9CQV8; -.
DR   TopDownProteomics; Q9CQV8-1; -. [Q9CQV8-1]
DR   Ensembl; ENSMUST00000018470; ENSMUSP00000018470; ENSMUSG00000018326. [Q9CQV8-1]
DR   GeneID; 54401; -.
DR   KEGG; mmu:54401; -.
DR   UCSC; uc008ntp.1; mouse. [Q9CQV8-1]
DR   CTD; 7529; -.
DR   MGI; MGI:1891917; Ywhab.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00940000153153; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; Q9CQV8; -.
DR   KO; K16197; -.
DR   OMA; KKQQMGR; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; Q9CQV8; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-MMU-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-MMU-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-MMU-165159; mTOR signalling.
DR   Reactome; R-MMU-166208; mTORC1-mediated signalling.
DR   Reactome; R-MMU-2028269; Signaling by Hippo.
DR   Reactome; R-MMU-392517; Rap1 signalling.
DR   Reactome; R-MMU-450385; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA.
DR   Reactome; R-MMU-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-MMU-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-MMU-5673000; RAF activation.
DR   Reactome; R-MMU-5674135; MAP2K and MAPK activation.
DR   Reactome; R-MMU-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-MMU-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   ChiTaRS; Ywhab; mouse.
DR   PRO; PR:Q9CQV8; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000018326; Expressed in 303 organ(s), highest expression level in substantia nigra.
DR   ExpressionAtlas; Q9CQV8; baseline and differential.
DR   Genevisible; Q9CQV8; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0017053; C:transcriptional repressor complex; ISO:MGI.
DR   GO; GO:0019899; F:enzyme binding; ISO:MGI.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0051219; F:phosphoprotein binding; ISO:MGI.
DR   GO; GO:0050815; F:phosphoserine residue binding; ISO:MGI.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:MGI.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; ISO:MGI.
DR   GO; GO:0045744; P:negative regulation of G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; ISO:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISO:MGI.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISO:MGI.
DR   GO; GO:0051291; P:protein heterooligomerization; ISO:MGI.
DR   GO; GO:0006605; P:protein targeting; IDA:MGI.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Isopeptide bond; Nitration;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367902.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000250|UniProtKB:P31946}.
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000005.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:P31946}.
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed.
FT                                {ECO:0000250|UniProtKB:P31946}.
FT   MOD_RES       2      2       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P31946}.
FT   MOD_RES       5      5       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      51     51       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000269|PubMed:9705322}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P31946}.
FT   MOD_RES      84     84       Nitrated tyrosine.
FT                                {ECO:0000244|PubMed:16800626}.
FT   MOD_RES     106    106       Nitrated tyrosine.
FT                                {ECO:0000244|PubMed:16800626}.
FT   MOD_RES     117    117       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P31946}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68251}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P31946}.
FT   CROSSLNK     51     51       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018634.
FT   CONFLICT     10     10       Q -> H (in Ref. 1; AAC14343).
FT                                {ECO:0000305}.
FT   CONFLICT     74     74       N -> D (in Ref. 1; AAC14343).
FT                                {ECO:0000305}.
FT   CONFLICT    126    126       D -> Y (in Ref. 2; BAE29538/BAE30278).
FT                                {ECO:0000305}.
FT   HELIX         5     17       {ECO:0000244|PDB:5WFX}.
FT   HELIX        21     33       {ECO:0000244|PDB:5WFX}.
FT   HELIX        40     68       {ECO:0000244|PDB:5WFX}.
FT   HELIX        75    105       {ECO:0000244|PDB:5WFX}.
FT   HELIX       107    110       {ECO:0000244|PDB:5WFX}.
FT   HELIX       114    134       {ECO:0000244|PDB:5WFX}.
FT   HELIX       137    161       {ECO:0000244|PDB:5WFX}.
FT   HELIX       167    182       {ECO:0000244|PDB:5WFX}.
FT   HELIX       187    202       {ECO:0000244|PDB:5WFX}.
FT   HELIX       203    207       {ECO:0000244|PDB:5WFX}.
FT   TURN        210    212       {ECO:0000244|PDB:5WFX}.
FT   HELIX       213    232       {ECO:0000244|PDB:5WFX}.
**
**   #################    INTERNAL SECTION    ##################
**EV ECO:0000244; PDB:5WFX; INT; 27-JUN-2018.
**EV ECO:0000244; PubMed:16800626; 001; 24-APR-2018.
**EV ECO:0000250; -; XXX; 01-JAN-1900.
**EV ECO:0000250; UniProtKB:P27348; 001; 24-APR-2018.
**EV ECO:0000250; UniProtKB:P31946; 001; 24-APR-2018.
**EV ECO:0000250; UniProtKB:P68251; 001; 24-APR-2018.
**EV ECO:0000269; PubMed:15883195; BER; 24-FEB-2017.
**EV ECO:0000269; PubMed:18604201; UHI; 30-MAR-2016.
**EV ECO:0000269; PubMed:20478393; UHI; 30-MAR-2016.
**EV ECO:0000269; PubMed:26047703; UHI; 30-MAR-2016.
**EV ECO:0000269; PubMed:9705322; XXX; 01-JAN-1900.
**EV ECO:0000305; -; XXX; 01-JAN-1900.
**SO UPD; 20141; 17-APR-2007.
**SO UPD; 38830; 26-JAN-2009.
**SO UPD; 62097; 29-AUG-2011.
**SO UPD; 74185; 10-JAN-2013.
**ZB ALB, 01-NOV-2005; MCB, 12-MAY-2006; ALG/LYG, 14-AUG-2006; LYG, 15-DEC-2006;
**ZB LYG, 15-DEC-2006; MAM, 09-MAY-2007; JAJ, 15-JAN-2008; ANN, 19-FEB-2009;
**ZB ALG/EMB, 17-SEP-2009; ALB/EMB, 16-OCT-2009; SHS, 19-MAR-2010;
**ZB SIB, 02-NOV-2010; UHI, 06-APR-2011; CLD, 29-APR-2011; ANN, 01-NOV-2011;
**ZB SHS, 10-NOV-2011; DLI, 14-NOV-2011; SHS, 14-JAN-2013; ANS, 06-JUN-2014;
**ZB UHI, 31-MAR-2016; ANN, 19-APR-2016; SHS, 23-MAY-2016; ANS, 13-SEP-2016;
**ZB LIF, 28-NOV-2016; ANS, 12-APR-2017;
SQ   SEQUENCE   246 AA;  28086 MW;  51C366ED85B38EED CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLILN ATQAESKVFY
     LKMKGDYFRY LSEVASGENK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
